NYSE:ADCT

Adc Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy ADCT

*Your capital is at risk

$3.97

+0.0100 (+0.253%)

At Close: Nov 17, 2025

Currently predicting for Wed, 19 Nov 2025

Trading levels for ADCT

Full Access. No Commitment. 14 Days Free!

Long & Short-Term Golden Star Lists

AI Stock Analysis*

Top 5 Candidates on Every List

Premium Lists

Ad-FREE Browsing

Advanced Stock Screener

GET STARTED!

Already have an account? Sign In Here

Fibonacci Support & Resistance Levels

Level	Price
R3	4.25	7.05%
R2	4.16	4.74%
R1	4.10	3.32%
Price	3.97
S1	3.92	-1.30%
S2	3.86	-2.73%
S3	3.77	-5.04%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	4.43	11.59%
R2	4.08	2.77%
R1	4.00	0.756%
Price	3.97
S1	3.65	-8.06%
S2	3.42	-13.85%
S3	3.11	-21.66%

ADCT Predictions History

1 month ago
svenaerts predicted that ADCT for Sep. 30th is going $8.00 (100.00%)

Rank:

2 months ago
belinda.golledge predicted that ADCT for Sep. 8th is going

Rank:

2 months ago
PredictionBot.Kathy predicted that ADCT for Aug. 29th is going $3.18 (3.61%)

2 months ago
PredictionBot.Warren predicted that ADCT for Aug. 29th is going $3.21 (4.45%)

2 months ago
belinda.golledge predicted that ADCT for Aug. 29th is going

Rank:

4 months ago
PredictionBot.Kathy predicted that ADCT for Jul. 7th is going $2.75 (1.85%)

4 months ago
PredictionBot.Warren predicted that ADCT for Jul. 7th is going $2.79 (3.24%)

4 months ago
belinda.golledge predicted that ADCT for Jul. 7th is going

Rank:

11 months ago
PredictionBot.Kathy predicted that ADCT for 2024-12-09 is going $3.03 (-5.74%)

11 months ago
PredictionBot.Warren predicted that ADCT for 2024-12-09 is going $3.07 (-4.41%)

ABOUT ADC THERAPEUTICS LTD

ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; Phase III clinical trial in combination with rituximab to treat relapsed or refractory DLBCL in second...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
UNIT $6.00	4.83%	Nov 04
TBPH $14.14	27.58%	Oct 23
A AMIX $1.12	2.68%	Oct 23
COCO $40.85	11.21%	Oct 23
LAUR $29.55	1.20%	Oct 22

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by